Development of a rat model for subacute exposure to the toxic organophosphate VX

Journal of the American College of Toxicology

Volumn 15, Issue SUPPL. 2, 1996, Pages

  Lenz, D E ^a,b   Maxwell, D M ^a,b   Austin, L W ^a,b  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

^b HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Ache inhibition; Nte inhibition; Rats; Subacute toxicity; VX

Indexed keywords

ACETYLCHOLINESTERASE; NEUROTOXIC ESTERASE; ORGANOPHOSPHATE;

ANIMAL MODEL; ARTICLE; CHEMICAL WARFARE; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; ENZYME ACTIVITY; LETHAL DOSE; MALE; NONHUMAN; RAT; TOXICITY; WEIGHT REDUCTION;

EID: 0030475081     PISSN: 07300913     EISSN: None     Source Type: Journal    
DOI: 10.3109/10915819609048339     Document Type: Article

References (40)

1. Bradford MM. (1976) A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-54.
2. Costa LG, Schwab BW, Murphy SD. (1982) Tolerance to anticholinesterase compounds in mammals. Toxicology 25:79-97.
3. Crowell JA, Parker RM, Bucci TJ, Caere JC. (1989) Neuropathy target esterase in hens after sarin and soman. J Biochem Toxicol 4:15-20.
4. Curry SH. (1977) Drug Disposition and Pharmacokinetics, 2nd ed. Oxford: Blackwell, 109-32.
5. Davies D, Holland P, Rumens MI. (1960). The relationship between chemical structure and neurotoxicity of alkyl organophosphorus compounds. Br J Pharmacol 15:271-8.
6. Davis CS, and Richardson RI. (1981) Organophosphorus compounds. In: Spencer PS, Schaumburg HH, eds. Experimental and Clinical Neurotoxicology, Baltimore: Williams and Wilkins, 527-44.
7. Dulaney MD, Hoskins B, Ho IK. (1985) Studies on low dose sub-acute administration of soman, sarin and tabun in the rat. Acta Pharmacol Toxicol 57:234-41.
8. Ember LR. (1990) Chemical weapons disposal: daunting challenges still ahead. Chem Eng News 68:9-19.
9. Fedorov LA, Svetlakova MS. (1995) Russian V-gas production and its legacy. ASA Newsletter 95-6:1,13.
10. Gordon JJ, Inns RH, Johnson MK, Leadbeater L, et al. (1983) The delayed neuropathic effects of nerve agents and some other organophosphorus compounds. Arch Toxicol 52:71-82.
11. Hudson CS, Foster RE. (1984) Ultrastructural pathology in mammalian skeletal muscle following acute and subacute exposure to pyridostigamine. Studies of dose-response and recovery. In: Lindstrom RE, ed. Proceedings of the Fourth Annual Chemical Defense Bioscience Review. Defense Technical Information Center Accession Number AD B089975, Aberdeen Proving Ground, MD: USAMRICD, 131-172.
12. Johnson MK. (1969a) A phosphorylation site in brain and the delayed neurotoxic effects of some organophosphorus compounds. Biochem J 111:487-95.
13. Johnson MK. (1969b) The delayed neurotoxic effects of some organophosphorus compounds. Biochem J 114:711-7.
14. Johnson MK. (1974) The primary biochemical lesion leading to the delayed neurotoxic effects of some organophosphorus esters. J Neureichem 23:785-9.
15. Johnson MK. (1975) Organophosphorus esters causing delayed neurotoxic effects. Arch Toxicol 34:259-88.
16. Johnson MK. (1977) Improved assay of neurotoxic esterase or screening organophosphates for delayed neurotoxicity potential. Arch Toxicol 32:113-5.
17. Johnson MK. (1987) Receptor or enzyme? The puzzle about NTE and organophosphate induced delayed polyneuropathy. Trends Pharmacol Sci 8:174-9.
18. Johnson MK, Read DJ, Benschop HP. (1985a). Interaction of the four stereoisomers of soman with acetylcholinesterase and neuropathy target esterase of hen brain. Biochem Pharmacol 34:1945-51.
19. Johnson MK, Williems JL, DeBisschop HC, Read DJ, Benschop HP. (1985b) Can soman cause delayed neuropathy? Fundam Appl Toxicol 5:5180-1.
20. Johnson MK, Williems JL, DeBisschop HC, Read DJ, Benschop HP. (1988) High doses of soman protect against organophosphorus-induced delayed polyneuropathy but tabun does not. Toxicol Appl Pharmacol 92:34-41.
21. Lenz DE, Maxwell DM. (1981) Inhibition of rat cerebrum acetylcholinesterase isoenzymes after acute administration of soman. Biochem Pharmacol 30:1369-71.
22. Lowndes HE, Baker T, Riker WE. (1974) Motor nerve dysfunction in delayed DFP neuropathy. Eur J Pharmacol 29:66-73.
23. Lotti M, Becker CE, Aminoff MI. (1984) Organophosphate polyneuropathy: pathogenesis and prevention. Neurology 34:658-62.
24. Lotti M, Caroldi S, Moretto A, et al. (1987) Central-peripheral delayed neuropathy caused by diisopropyl phosphorofluoridate (DFP): segregation of peripheral nerve and spinal cord effects using biochemical, clinical and morphological criteria. Toxicol Appl Pharmacol 88:87-96.
25. Maynard RL, Beswick FW. (1992) Organophosphorus compounds as chemical warfare agents. In: Ballantyne B, Marrs TC, eds. Clinical and Experimental Toxicology of Organophosphates and Carbamates Oxford: Butterworth, 373-85.
26. Reveley AV, Sabourin TD, Moore MT, GOSS B. (1986) Distribution of neurotoxic esterase activity in the brain of control and diisopropyl phosphorofluoridate-treated hens: in vivo and in vitro exposure. Toxicol Lett 31:45-56.
27. Siakotos AN, Filbert M, Hester R. (1969) A specific radioisotopic assay for acetylcholinesterase and pseudocholinesterase in brain and plasma. Biochem Med 3:1-12.
28. Sikora-VanMeter KC, VanMeter WG, Willets J, Grieve PA (1983) Fine structural changes in cat L7 ventral hom neurons after chronic sub LD50 DFP. Brain Res Bull 10:631-8.
29. Sikora-VanMeter KC, Ellenberger T, VanMeter WG (1985) Neurotoxic changes in cat neurohypophysis after single and multiple exposures to diisopropylfluorophosphate and soman. Fund Appl Toxicol 5:1087-96.
30. Soliman SA, Curley A, El-Sebae AK (1981) A direct method to assay neurotoxic esterase activity. Toxicol Lett 9:283-8.
31. Sterri SH, Lyngaas S, Fonnum F (1980) Toxicity of soman after repeated injection of sublethal doses in rat.Acta Pharmacol Toxicol 46:1-7.
32. Veronesi B. (1984a) Effect of metabolic inhibition with piperonyl butoxide on rodent sensitivity to tri-orthocresyl phosphate. Exp Neural 85:651-60.
33. Veronesi B (1984b). A rodent model of organophosphorus-induced delayed neuropathy: Distribution of central (spinal cord) and peripheral nerve damage. Neuropath Appl Neurobiol 10:357-68.
34. Veronesi B, Abou-Donia MB. (1982) Central and peripheral neuropathology induced in rats by tri-O-cresyl phosphate (TOCP). Vet Hum Toxicol 24:222.
35. Veronesi B, Padilla S. (1985) Phenylmethylsulfonyl fluoride protects rats from mipafox-induced delayed neuropathy. Toxicol Appl Pharmacol 81:258-64.
36. Veronesi B, Padilla S, Lyerly D. (1986) The correlation between neurotoxic esterase inhibition and mipafoxinduced neuropathic damage in rats. Neurotoxicology 1:207-16.
37. Vranken MA, DeBisschop HC, Willems JL (1982) In vitro inhibition of neurotoxic esterase by organophosphorus nerve agents. Arch Int Pharmacodyn 260:316-8.
38. Wilson BW, Henderson JD, Chow E, et al. (1988a) Toxicity of an acute dose of agent VX and other organophosphorus esters in the chicken. J Toxicol Environ Health 23:103-13.
39. Wilson BW, Henderson JD, Kellner TP, Goldman M, Higgins RJ, Dacre JC. (1988b) Toxicity of repeated doses of organophosphorus esters in the chicken. J Toxicol Environ Health 23:115-26.
40. Zech R, Chemnitius JM. (1987) Neurotoxicant sensitive esterase: enzymology and pathophysiology of organophosphorus ester-induced delayed neuropathy. Prog Neurobiol 29:193-218.